Supplementary Table 2 from Cancer Stem Cell Vaccination Confers Significant Antitumor Immunity

Autor: Qiao Li, Alfred E. Chang, Shiang Huang, Xiao-Lian Zhang, Yingxin Xu, Mark E.P. Prince, Jeffrey S. Moyer, Max S. Wicha, Christophe Ginestier, Mu Li, Ji Yet, Martin Egenti, Seagal Teitz-Tennenbaum, Fang Zheng, Qin Pan, Ning Ning

PDF file - 57K

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64acd1293d8b200c981d3c6a54e7e668
https://doi.org/10.1158/0008-5472.22395251

Cancer Stem Cell Vaccination Confers Significant Antitumor Immunity

Autor: Max S. Wicha, Xiao-Lian Zhang, Mark E. Prince, Yingxin Xu, Jeffrey S. Moyer, Martin Egenti, Ji Yet, Ning Ning, Qiao Li, Mu Li, Seagal Teitz-Tennenbaum, Christophe Ginestier, Fang Zheng, Shiang Huang, Qin Pan, Alfred E. Chang

Publikováno v: Cancer Research
Cancer Research, American Association for Cancer Research, 2012, 72 (7), pp.1853-1864. ⟨10.1158/0008-5472.CAN-11-1400⟩

Most studies of cancer stem cells (CSC) involve the inoculation of cells from human tumors into immunosuppressed mice, preventing an assessment on the immunologic interactions and effects of CSCs. In this study, we examined the vaccination effects pr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0305274714236fd08e7a9b4677146b1
https://hal.archives-ouvertes.fr/hal-01431939

Cancer stem cell vaccine inhibits metastases of primary tumors and induces humoral immune responses against cancer stem cells

Autor: Shiang Huang, Yangyang Hu, Alfred E. Chang, Max S. Wicha, Jian Chuan Xia, Lin Lu, Huimin Tao, Martin Egenti, Quanning Chen, Guoshun Shu, Qiao Li, John H. Owen, Mark E. Prince, Jeffrey S. Moyer

Publikováno v: Oncoimmunology

The inability to target cancer stem cells (CSC) may be a significant factor contributing to treatment failure. We have developed a strategy to target the CSC populations in melanoma and squamous cell carcinoma using CSC lysate-pulsed dendritic cells

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ffea34ef2c44133523ec6f97ad1e472
https://doi.org/10.4161/2162402x.2014.990767

Abstract 487: Effector B cells in cancer adoptive immunotherapy

Autor: Martin Egenti, Qiao Li, Huimin Tao, Alfred E. Chang, Lin Lu

Publikováno v: Cancer Research. 73:487-487

Successful anti-cancer treatment will have to appropriately stimulate both humoral as well as cellular immunity. To test this hypothesis, we reported that simultaneous targeting of CD3 on T cells and CD40 on B cells augmented the antitumor reactivity

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f29fc59c165c1b546ef22f090779f201
https://doi.org/10.1158/1538-7445.am2013-487

Abstract 4840: Blockade of IL-10 production in effector B cells significantly increases their therapeutic efficacy in cancer adoptive immunotherapy

Autor: Qin Pan, Martin Egenti, Qiao Li, Alfred E. Chang, Fang Zheng

Publikováno v: Cancer Research. 72:4840-4840

We have previously reported the antitumor reactivity of adoptively transferred effector B cells and the mechanisms by which they mediate tumor regression in a spontaneous metastasis model. 4T1 breast cancer cells were inoculated into syngeneic Balb/c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::55e9eb6325f26d308756271215d9572b
https://doi.org/10.1158/1538-7445.am2012-4840